News Brief
Why This $4 Billion Biotech Investor is Now Betting Small on AI-Powered Biology
Why a $4 Billion Investor is Now Betting Small on AI-Powered Biology Vijay Pande spent years managing roughly $4 billion in biotech investments at venture capital giant a16z. Last year, he left to start VZVC — a much smaller fund with a different approach: fewer bets, more focus on AI. In